Aveeno Anti-itch Concentrated Lotion
NDC Package 69968-0475-4

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Aveeno Anti-itch Concentrated (zinc oxide, ferric oxide red, and pramoxine hydrochloride) lotions is adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily. This formulation utilizes a lotion delivery system. Marketed by Kenvue Brands Llc, this product is identified by NDC 69968-0475 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
69968-0475-4
Package Description
118 mL in 1 BOTTLE
Product Code
69968-0475
11-Digit Billing Format
69968047504
RxNorm Crosswalk
  • RxCUI: 1233698 - calamine 3 % / pramoxine HCl 1 % Topical Lotion
  • RxCUI: 1233698 - calamine 30 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Lotion
  • RxCUI: 1233698 - calamine 3 % / pramoxine hydrochloride 1 % Topical Lotion

Clinical Specifications

Proprietary Name
Aveeno Anti-itch Concentrated
Non-Proprietary Name
Zinc Oxide, Ferric Oxide Red, And Pramoxine Hydrochloride
Substance Name
Ferric Oxide Red; Pramoxine Hydrochloride; Zinc Oxide
Dosage Form
Lotion - An emulsion, liquid1 dosage form. This dosage form is generally for external application to the skin.2
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
Adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily. Children under 2 years of age: ask a doctor.

Regulatory & Marketing

Labeler Name
Kenvue Brands Llc
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
03-01-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69968-0475-4 identifies a specific commercial package of 118 ml in 1 bottle of Aveeno Anti-itch Concentrated, a human over the counter drug labeled by Kenvue Brands Llc. This lotion is formulated for topical use and contains ferric oxide red; pramoxine hydrochloride; zinc oxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kenvue Brands Llc on March 01, 2019. The current certification is valid through December 31, 2026.

How is this Kenvue Brands Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69968047504. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
69968-0475-4
11-Digit CMS (5-4-2)
69968-0475-04

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.